Galveston National Laboratory Operations

加尔维斯顿国家实验室(GNL)将是一座新的七层建筑，可容纳83,433净可用空间 一平方英尺的最先进的BSL2到BSL4实验室空间，旨在支持 NIAID生物防御网络的研究。该提案描述了其运营计划，以及如何 GNL将满足与确定和验证有效对策有关的关键国家需求 自然出现的传染病和生物恐怖主义的威胁。GNL将作为一个 UTMB园区内的合并职能实体，与已建立的UTMB园区有多种联系 允许GNL最大限度地利用技术和技术的深度和广度 驻留在大学其他地方的专业知识和资源。GNL研究和设施 行动将向GNL主任报告，后者将向医学院院长报告， UTMB主席。生物安全和安保职能将直接向UTMB负责 商务事务，他是联邦指定的UTMB负责官员。科学研究、建筑 运营和业务活动将由GNL围绕以下内容构建的中央管理核心进行管理 行政领导小组由主任、科学主任、研究副主任、 以及负责设施的副主任。通过GNL运营委员会并与NIAID协商 计划办公室，这个领导团队将领导一个多学科的研究努力，以支持GNL 和NIAID生物防御网，涉及九个研究支助核心(新兴和高级研究支助核心)的活动 风险病原体；BSL3研究；高级兽医服务；昆虫服务；协作 研究服务；实验病理学服务；高级影像服务；高级 技术和监管事务)和四个设施支助核心(设施和后勤； 生物遏制工程；卫生、安全和培训服务；以及安保)。研究的重点将是 与NIAID计划办公室和NIAID生物防御的其他调查人员协商建立 在这方面，教科文组织与教科文组织建立了一个网络，并听取了一个杰出的外部科学咨询委员会的建议。田野调查 由新兴和高风险病原体核心管理的团队将与来自 实验病理学核心，以协助GNL应对未来因 新出现的传染病或生物恐怖袭击。

The Galveston National Laboratory (GNL) will be a new, seven-story building containing 83,433 net usable square feet of state-of-the-art BSL2 through BSL4 laboratory space designed and constructed to support the research of the NIAID Biodefense Network. This proposal describes plans for its operation, and how the GNL will meet critical national needs related to the identification and validation of effective countermeasures for both naturally emerging infectious diseases and the threat of bioterrorism. The GNL will be operated as a consolidated functional entity on the UTMB campus, with multiple linkages to established UTMB campus operations allowing the GNL to take maximum advantage of the depth and breadth of technical and professional expertise and resources residing elsewhere in the University. GNL research and facility operations will report to the Director of the GNL, who will report to the Dean of the School of Medicine and President of UTMB. Biosafety and security functions will report directly to UTMB's Vice President for Business Affairs, who is the federally designated Responsible Official at UTMB. Scientific research, building operations, and business activities will be managed by the GNL's central Administrative Core built around an executive leadership team comprised of the Director, Scientific Director, Associate Director for Research, and Associate Director for Facilities. Through a GNL Operations Council and in consultation with the NIAID Program Office, this leadership team will direct a multidisciplinary research effort in support of both the GNL and NIAID Biodefense Network involving the activities of nine Research Support Cores (Emerging and High Risk Pathogens; BSL3 Research; Advanced Veterinary Services; Insectary Services; Collaborative Research Services; Experimental Pathology Services; Advanced Imaging Services; Advanced Technologies; and Regulatory Services) and four Facilities Support Cores (Facilities and Logistics; Biocontainment Engineering; Health, Safety and Training Services; and Security). Research priorities will be established in consultation with the NIAID Program Office and other investigators of the NIAID Biodefense Network and with the advice of a distinguished external Scientific Advisory Board. A field Investigations team managed by the Emerging & High Risk Pathogens Core will work with laboratory support from the Experimental Pathology Core to assist the GNL in responding to any future national emergency due to a newly emergent infectious disease or bioterrorist attack.